Mustafa Araz

421 total citations
18 papers, 228 citations indexed

About

Mustafa Araz is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Mustafa Araz has authored 18 papers receiving a total of 228 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Genetics. Recurrent topics in Mustafa Araz's work include Diabetes Management and Research (3 papers), Diabetes and associated disorders (3 papers) and Diabetes Treatment and Management (3 papers). Mustafa Araz is often cited by papers focused on Diabetes Management and Research (3 papers), Diabetes and associated disorders (3 papers) and Diabetes Treatment and Management (3 papers). Mustafa Araz collaborates with scholars based in Türkiye and China. Mustafa Araz's co-authors include Vahap Okan, Mehmet Tarakçıoğlu, Ayşe Binnur Erbağcı, A. Şükrü Aynacıoğlu, Yalçı́n Kepekçi, Muradiye Nacak, Kıvanç Güngör, İclal Meram, Sibel Oğuzkan Balcı and Sacide Pehlıvan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Medicine and Diabetes Research and Clinical Practice.

In The Last Decade

Mustafa Araz

16 papers receiving 221 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mustafa Araz Türkiye 8 60 60 53 43 41 18 228
Daniela Cugino Italy 7 66 1.1× 34 0.6× 78 1.5× 39 0.9× 33 0.8× 8 272
Ronak Patel United States 8 28 0.5× 48 0.8× 30 0.6× 111 2.6× 10 0.2× 25 308
A. González Spain 9 40 0.7× 34 0.6× 22 0.4× 26 0.6× 47 1.1× 21 311
Malorie Chabot-Blanchet Canada 7 36 0.6× 79 1.3× 20 0.4× 91 2.1× 8 0.2× 10 252
Filip Sköldberg Sweden 10 26 0.4× 49 0.8× 152 2.9× 14 0.3× 41 1.0× 20 355
Ryuji Okamura Japan 9 29 0.5× 31 0.5× 25 0.5× 34 0.8× 12 0.3× 39 282
N. Ansorge Germany 9 32 0.5× 52 0.9× 97 1.8× 19 0.4× 50 1.2× 15 358
Agathi Karakosta Greece 10 36 0.6× 14 0.2× 72 1.4× 21 0.5× 16 0.4× 23 257
M. Schweditsch Austria 7 55 0.9× 90 1.5× 16 0.3× 21 0.5× 21 0.5× 8 401
Grażyna Kurzawińska Poland 10 37 0.6× 19 0.3× 19 0.4× 33 0.8× 30 0.7× 55 344

Countries citing papers authored by Mustafa Araz

Since Specialization
Citations

This map shows the geographic impact of Mustafa Araz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mustafa Araz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mustafa Araz more than expected).

Fields of papers citing papers by Mustafa Araz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mustafa Araz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mustafa Araz. The network helps show where Mustafa Araz may publish in the future.

Co-authorship network of co-authors of Mustafa Araz

This figure shows the co-authorship network connecting the top 25 collaborators of Mustafa Araz. A scholar is included among the top collaborators of Mustafa Araz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mustafa Araz. Mustafa Araz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Çaklılı, Özge Telci, Mustafa Araz, Nurdan Gül, et al.. (2025). Successful treatment with rituximab of a type 2 diabetes patient with antibody-mediated insulin resistance syndrome: A case report. Medicine. 104(29). e43501–e43501.
2.
Acar, Nuray, et al.. (2021). Hospitalisation Cost of Diabetic Patients with Foot Ulcers: A Retrospective Descriptive Analysis from Turkey. Endocrinology research and practice.. 25(3). 255–260.
3.
Sayıner, Zeynel Abidin, et al.. (2020). The Relationship Between Dipeptidyl Peptidase-4 Inhibitor Usage and Asymptomatic Amylase Lipase Increment in Type 2 Diabetes Mellitus Patients. Turkish Journal of Pharmaceutical Sciences. 17(1). 68–73. 4 indexed citations
4.
Nacak, Muradiye, et al.. (2018). Association of melatonin receptor 1 B gene (rs10830963 and rs9192552) polymorphısm with adolescent obesity and related comorbidities in Turkey. Journal of International Medical Research. 46(8). 3086–3096. 2 indexed citations
5.
Nacak, Muradiye, et al.. (2017). Adolescent obesity and the role of the fat mass and obesity-associated gene polymorphism. Clinical and investigative medicine. 40(6). E235–E242. 3 indexed citations
6.
Korkmaz, Hakan, et al.. (2015). Liraglutide-related cholelithiasis. Aging Clinical and Experimental Research. 27(5). 751–753. 7 indexed citations
7.
Nacak, Muradiye, Sibel Oğuzkan Balcı, Mustafa Araz, et al.. (2012). Childhood Obesity and the Role of Dopamine D2 Receptor and Cannabinoid Receptor-1 Gene Polymorphisms. Genetic Testing and Molecular Biomarkers. 16(12). 1408–1412. 14 indexed citations
8.
Balcı, Sibel Oğuzkan, et al.. (2012). Mitochondrial uncoupling protein 2 (UCP2) gene polymorphisms are associated with childhood obesity and related metabolic disorders. Journal of Pediatric Endocrinology and Metabolism. 0(0). 1–7. 17 indexed citations
9.
Akalın, Sema, Mustafa Araz, Mustafa Kemal Balcı, et al.. (2011). Biphasic Insulin Analogues in Type 2 Diabetes: Expert Panel Recommendations. SHILAP Revista de lepidopterología. 1 indexed citations
10.
Araz, Mustafa, et al.. (2006). Frequency of Neonatal Hypoglycemia in Large for Gestational Age Infants of Non-Diabetic Mothers in a Community Maternity Hospital. Acta Medica (Hradec Kralove Czech Republic). 49(4). 237–239. 12 indexed citations
11.
Araz, Mustafa, et al.. (2004). Frequency of silent myocardial ischemia in type 2 diabetic patients and the relation with poor glycemic control. Acta Diabetologica. 41(2). 38–43. 21 indexed citations
12.
Okan, Vahap, et al.. (2002). INCREASED FREQUENCY OF HCV BUT NOT HBV INFECTION IN TYPE 2 DIABETIC PATIENTS IN TURKEY. International Journal of Clinical Practice. 56(3). 175–177. 38 indexed citations
13.
Erbağcı, Ayşe Binnur, et al.. (2002). Serum prolidase activity as a marker of osteoporosis in type 2 diabetes mellitus. Clinical Biochemistry. 35(4). 263–268. 60 indexed citations
14.
Araz, Mustafa, et al.. (2002). ANGIOTENSIN CONVERTING ENZYME GENE POLYMORPHISM AND GLOMERULAR FILTRATION RATE CHANGES IN TYPE 2 DIABETIC PATIENTS. International Journal of Clinical Practice. 56(6). 416–418. 3 indexed citations
15.
Araz, Mustafa, et al.. (2002). Angiotensin-converting enzyme gene polymorphism and coronary heart disease in Turkish type 2 diabetic patients. Acta Cardiologica. 57(4). 265–269. 6 indexed citations
16.
Araz, Mustafa, et al.. (2002). Hypothyroidism presenting as a polymyositis like syndrome. Case report. 11(1). 36–37. 1 indexed citations
17.
Araz, Mustafa, et al.. (2001). Angiotensin-converting enzyme gene polymorphism and microvascular complications in Turkish type 2 diabetic patients. Diabetes Research and Clinical Practice. 54(2). 95–104. 33 indexed citations
18.
Araz, Mustafa, et al.. (2001). Association Between Polymorphism of the Angiotensin I Converting Enzyme Gene and Hypertension in Turkish Type II Diabetic Patients. Acta Medica (Hradec Kralove Czech Republic). 44(1). 29–32. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026